Clinical Trial Update: Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cisplatin and 5-FU with or without panitumumab for nonresectable, advanced or metastatic esophageal squamous cell cancer has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Esophageal Squamous Cell Cancer | Phase 3 | Status: TERMINATED